SCHEMBL4956645

SCHEMBL4956645

N=c1scc(-c2ccc(SCC(=O)O)cc2)n1Cc1ccc(CP(=O)(OF)OF)c(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4954856 0.87 MCHR1 (0.33)
SCHEMBL4956641 0.81 PTPN1 (0.40)
SCHEMBL4957772 0.78 HTR7 (0.31)
SCHEMBL4958556 0.75 PTPN1 (0.32)
SCHEMBL4955431 0.74 FZD7 (0.40)
SCHEMBL4957484 0.72 RAB9A (0.37)
SCHEMBL4959254 0.70 RAB9A (0.36)
SCHEMBL4957776 0.69 MEN1 (0.35)
SCHEMBL4957923 0.69 GCGR (0.43)
SCHEMBL4891795 0.69 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200371-A1 THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES IMPINJ, INC. 2008-08-21 US claimed
EP-1841749-A1 DERIVATIVES OF THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES Metabasis Therapeutics, Inc. (US) 2007-10-10 EP claimed
US-20060194768-A1 Thiazole and thiadiazole inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2006-08-31 US claimed
WO-2006028970-A1 DERIVATIVES OF THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES CENGENT THERAPEUTICS, INC. (US) 2006-03-16 WO claimed